电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

PHLPP2 Protein (AA 766-1043) (His tag)

PHLPP2 宿主: 人 宿主: 大肠杆菌(E. Coli) Recombinant Greater than 95 % as determined by SDS-PAGE WB, ELISA
产品编号 ABIN7124383
发货至: 中国
  • 抗原 See all PHLPP2 蛋白
    PHLPP2 (PH Domain and Leucine Rich Repeat Protein Phosphatase 2 (PHLPP2))
    蛋白类型
    Recombinant
    产品特性
    AA 766-1043
    宿主
    • 3
    • 1
    资源
    • 2
    • 1
    • 1
    大肠杆菌(E. Coli)
    标记
    This PHLPP2 protein is labelled with His tag.
    应用范围
    Western Blotting (WB), ELISA
    纯度
    Greater than 95 % as determined by SDS-PAGE
    过滤
    0.2 μm filtered
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    限制
    仅限研究用
  • 状态
    Lyophilized
    溶解方式
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    缓冲液
    Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
    储存条件
    4 °C,-20 °C
    储存方法
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    有效期
    12 months
  • 抗原
    PHLPP2 (PH Domain and Leucine Rich Repeat Protein Phosphatase 2 (PHLPP2))
    别名
    PHLPP2 (PHLPP2 产品)
    别名
    PHLPPL Protein, phlppl Protein, AI481772 Protein, C130044A18Rik Protein, Phlppl Protein, RGD1562857 Protein, PH domain and leucine rich repeat protein phosphatase 2 Protein, PH domain and leucine rich repeat protein phosphatase 2 S homeolog Protein, PHLPP2 Protein, phlpp2.S Protein, phlpp2 Protein, Phlpp2 Protein
    背景
    KIAA0931, PH domain and leucine rich repeat protein phosphatase 2, PH domain leucine rich repeat protein phosphatase like, PH domain leucine-rich repeat-containing protein phosphatase 2, PH domain leucine-rich repeat-containing protein phosphatase-like, PHLP2_HUMAN, PHLPP like, PHLPP-like, Phlpp2, PHLPPL
    分子量
    30.5 kDa
    UniProt
    Q6ZVD8
    途径
    PI3K-Akt Signaling, Fc-epsilon Receptor Signaling Pathway
You are here: